The RDAF publishes the report from its workshop on post-marketing registries

    8 Nov, 2023

    The report from the RDAF multi-stakeholder workshop on post-marketing registries for rare diseases, which took place on 21 September 2023 in Basel, is now available.

    The workshop fostered an inclusive dialogue between academia, healthcare professionals, industry, patient representatives and digital health organizations that helped develop a mutual understanding on the main challenges and debate on solutions for action. Attendees delved into a range of topics related to post marketing registries for rare diseases, including stakeholders’ role and involvement, goal definition, governance, funding and data collection and (re)use.

    Read the full report to find out more about the discussion outcomes.

    Continue reading

    RDAF position on the KVV / KLV revision

    The revision of the Health Insurance Ordinance (KVV/OAMal) and the Health Benefits Ordinance (KLV/OPAS), presented by the Federal Council in September, will further deteriorate access to treatment and quality of care for rare disease patients in Switzerland. The...

    RDAF hosts multi-stakeholder workshop on post-marketing registries

    The Rare Disease Action Forum (RDAF) will host a multi-stakeholder workshop on post-marketing registries for rare diseases on 21 September 2023 (14.00 – 19.00 CEST) in Basel, Switzerland. The workshop will gather stakeholders active in the rare disease field to...